Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Rhythm Pharmaceuticals, Inc. (RYTM) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$51.30M |
|
$-54.28M |
|
$5.50M |
|
$45.80M |
|
$103.95M |
|
$-52.65M |
|
$-0.14M |
|
$-52.79M |
|
$-52.79M |
|
$-52.90M |
|
$-52.90M |
|
$-52.90M |
|
$-52.90M |
|
$-52.65M |
|
$-52.35M |
|
66.26M |
|
66.26M |
|
$-0.82 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$494.80M |
|
$0.24M |
|
$12.07M |
|
$506.87M |
|
$104.27M |
|
-- |
|
$106.92M |
|
$211.19M |
|
$148.82M |
|
$290.15M |
|
$295.68M |
|
66.68M |
|
| Cash Flow Statement Financials | |
$-90.29M |
|
$-167.50M |
|
$220.91M |
|
$89.60M |
|
$52.75M |
|
$-36.85M |
|
$47.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.75 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
89.28% |
|
-102.64% |
|
-102.64% |
|
-- |
|
-102.91% |
|
-105.81% |
|
$-130.29M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.25 |
|
1.55 |
|
57.96 |
|
-35.55% |
|
-18.23% |
|
-10.44% |
|
-17.89% |
|
$4.43 |
|
$-1.97 |
|
$-1.36 |
|